| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
The University of Texas M. D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas 78957
In a previous study, we showed that synchronized proliferation of mouse epidermis was induced by topical application of 12-O-tetradecanoyl-phorbol 13-acetate. Here, we used this system to study modifications in the cell cycle regulation and kinetics of proliferation in transgenic mice that overexpress cyclin D1 (K5D1 mice). Overexpression of cyclin D1 corresponded with an increase of proliferation in the epidermis of these transgenic mice. After proliferation reached its peak, the labeling index remained high in the transgenics, but not in the wild-type animals. In addition, cyclin D1/cyclin-dependent kinase (CDK) complex formation increased in the transgenic mice and was correlated with elevated CDK4 and CDK6 kinase activities. However, the increased CDK activities were not sufficient to effect mouse skin tumor development. In summary, these results show that cyclin D1 has a unique growth-promoting role in tumor development, but does not act as an oncogene independent of ras activity.
This article has been cited by other articles:
![]() |
T. Moore, L. Beltran, S. Carbajal, S. Strom, J. Traag, S. D. Hursting, and J. DiGiovanni Dietary Energy Balance Modulates Signaling through the Akt/Mammalian Target of Rapamycin Pathways in Multiple Epithelial Tissues Cancer Prevention Research, June 1, 2008; 1(1): 65 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Garcia-Espana, E. Salazar, T.-T. Sun, X.-R. Wu, and A. Pellicer Differential Expression of Cell Cycle Regulators in Phenotypic Variants of Transgenically Induced Bladder Tumors: Implications for Tumor Behavior Cancer Res., February 15, 2005; 65(4): 1150 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Chan, S. Carbajal, K. Kiguchi, J. Clifford, S. Sano, and J. DiGiovanni Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis Cancer Res., April 1, 2004; 64(7): 2382 - 2389. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xu, S. Lyle, Y. Liu, B. Solky, and G. Cotsarelis Differential Expression of Cyclin D1 in the Human Hair Follicle Am. J. Pathol., September 1, 2003; 163(3): 969 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Y. Y. Fong, R. Mancini, H. Nakagawa, A. K. Rustgi, and K. Huebner Combined Cyclin D1 Overexpression and Zinc Deficiency Disrupts Cell Cycle and Accelerates Mouse Forestomach Carcinogenesis Cancer Res., July 15, 2003; 63(14): 4244 - 4252. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Nelsen, D. G. Rickheim, M. M. Tucker, L. K. Hansen, and J. H. Albrecht Evidence That Cyclin D1 Mediates Both Growth and Proliferation Downstream of TOR in Hepatocytes J. Biol. Chem., January 31, 2003; 278(6): 3656 - 3663. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Stull, M. M. Richert, A. V. Loladze, and T. L. Wood Requirement for IGF-I in Epidermal Growth Factor-Mediated Cell Cycle Progression of Mammary Epithelial Cells Endocrinology, May 1, 2002; 143(5): 1872 - 1879. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamamoto, T. Ochiya, F. Takeshita, H. Toriyama-Baba, K. Hirai, H. Sasaki, H. Sasaki, H. Sakamoto, T. Yoshida, I. Saito, et al. Enhanced Skin Carcinogenesis in Cyclin D1-conditional Transgenic Mice: Cyclin D1 Alters Keratinocyte Response to Calcium-induced Terminal Differentiation Cancer Res., March 1, 2002; 62(6): 1641 - 1647. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Reichelt and T. M. Magin Hyperproliferation, induction of c-Myc and 14-3-3{sigma}, but no cell fragility in keratin-10-null mice J. Cell Sci., January 7, 2002; 115(13): 2639 - 2650. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Todd, P.W. Hinds, K. Munger, A.K. Rustgi, O.G. Opitz, Y. Suliman, and D.T. Wong CELL CYCLE DYSREGULATION IN ORAL CANCER Crit. Rev. Oral. Biol. Med., January 1, 2002; 13(1): 51 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Nelsen, D. G. Rickheim, N. A. Timchenko, M. W. Stanley, and J. H. Albrecht Transient Expression of Cyclin D1 Is Sufficient to Promote Hepatocyte Replication and Liver Growth in Vivo Cancer Res., December 1, 2001; 61(23): 8564 - 8568. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Curran, F. S. Laverty, D. Campbell, J. Macdiarmid, and J. B. Wilson Epstein-Barr Virus Encoded Latent Membrane Protein-1 Induces Epithelial Cell Proliferation and Sensitizes Transgenic Mice to Chemical Carcinogenesis Cancer Res., September 1, 2001; 61(18): 6730 - 6738. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xia, S. Qian, S. Soriano, Y. Wu, A. M. Fletcher, X.-J. Wang, E. H. Koo, X. Wu, and H. Zheng Loss of presenilin 1 is associated with enhanced beta -catenin signaling and skin tumorigenesis PNAS, August 17, 2001; (2001) 191284198. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Miliani de Marval, I. B. Gimenez-Conti, M. LaCava, L. A. Martinez, C. J. Conti, and M. L. Rodriguez-Puebla Transgenic Expression of Cyclin-Dependent Kinase 4 Results in Epidermal Hyperplasia, Hypertrophy, and Severe Dermal Fibrosis Am. J. Pathol., July 1, 2001; 159(1): 369 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Rodriguez-Puebla, M. LaCava, P. L. Miliani de Marval, J. L. Jorcano, E. R. Richie, and C. J. Conti Cyclin D2 Overexpression in Transgenic Mice Induces Thymic and Epidermal Hyperplasia whereas Cyclin D3 Expression Results Only in Epidermal Hyperplasia Am. J. Pathol., September 1, 2000; 157(3): 1039 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xia, S. Qian, S. Soriano, Y. Wu, A. M. Fletcher, X.-J. Wang, E. H. Koo, X. Wu, and H. Zheng Loss of presenilin 1 is associated with enhanced beta -catenin signaling and skin tumorigenesis PNAS, September 11, 2001; 98(19): 10863 - 10868. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |